Orión Erenhú Rodríguez (@erenhu_gonzalez) 's Twitter Profile
Orión Erenhú Rodríguez

@erenhu_gonzalez

Adscrito al Servicio de Urología HMRE Guadalajara Jalisco #UroHCM 🥇; Urólogo Certificado.

ID: 728369934045224964

calendar_today05-05-2016 23:44:59

934 Tweet

606 Followers

524 Following

Juan E Losa. Infectólogo. Médico. HUFA. URJC. (@juanelosag) 's Twitter Profile Photo

El diagnóstico de infección urinaria recurrente es más difícil en mujeres mayores debido a las mayores tasas de síntomas genitourinarios crónicos (vejiga hiperactiva o síndrome genitourinario de la menopausia) (sigue)

Daniel E Spratt (@drspratticus) 's Twitter Profile Photo

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

Congrats #MichaelOng SOUMYAJIT ROY for oral Ab#5002 ASCO #ASCO25👉bit.ly/43NyyfY👉Real-world IRONMAN registry of mHSPC #prostatecancer (n=1288 pts)👉PSA<0.02 after 6-12 mo of Rx had best prognosis (3-yr OS 92.7%)👇Dan George OncoAlert UroToday.com PCF Science

Congrats #MichaelOng <a href="/Soum_Roy_RadOnc/">SOUMYAJIT ROY</a> for oral Ab#5002 <a href="/ASCO/">ASCO</a> #ASCO25👉bit.ly/43NyyfY👉Real-world IRONMAN registry of mHSPC #prostatecancer (n=1288 pts)👉PSA&lt;0.02 after 6-12 mo of Rx had best prognosis (3-yr OS 92.7%)👇<a href="/Daniel_J_George/">Dan George</a> <a href="/OncoAlert/">OncoAlert</a> <a href="/urotoday/">UroToday.com</a> <a href="/PCF_Science/">PCF Science</a>
Michael Hofman (@drmhofman) 's Twitter Profile Photo

Don't miss the first-in-human VIOLET study being presented #ASCO25 ASCO Monday June 2 3:00 PM New Frontiers in Prostate-Specific Membrane Antigen Radioligand Therapy (awesome research being presented in this session - don't miss the other talks) In press The Lancet Oncology

Michael Hofman (@drmhofman) 's Twitter Profile Photo

#VIOLET Study of Terbium-161 (Tb-161) Beta/Auger therapy ASCO #ASCO25 First prospective trial of Terbium-161 in any tumour type 🟣 30 patient trial in prostate cancer. No dose limiting toxicities at highest level of radioactivity (7.4 GBq) 🟣 Very few side effects: 1 grade 3

#VIOLET Study of Terbium-161 (Tb-161) Beta/Auger therapy <a href="/ASCO/">ASCO</a> #ASCO25

First prospective trial of Terbium-161 in any tumour type
🟣 30 patient trial in prostate cancer. No dose limiting toxicities at highest level of radioactivity (7.4 GBq)
🟣 Very few side effects: 1 grade 3
Advanced Prostate Cancer Consensus Conference (@apccc_lugano) 's Twitter Profile Photo

FDA approves darolutamide for metastatic castration-sensitive prostate cancer fda.gov/drugs/resource… On June 3, 2025, the FDA🇺🇸 approved darolutamide for the treatment of metastatic castration-sensitive #ProstateCancer (mCSPC), expanding its previous indication in combination

FDA approves darolutamide for metastatic castration-sensitive prostate cancer

fda.gov/drugs/resource…

On June 3, 2025, the FDA🇺🇸 approved darolutamide for the treatment of metastatic castration-sensitive #ProstateCancer (mCSPC), expanding its previous indication in combination
Urologeman (Nariman Gadzhiev) (@urologeman) 's Twitter Profile Photo

🚨BREAKING: Just received footage of a new dinosaur species living in the human bladder. The little guy 🦖 was rescued and released back into the wild. Endourology never ceases to surprise. #urology #bladderdino

Veeru Kasi (@veerukasi) 's Twitter Profile Photo

Exciting #WASHOUT preliminary findings emergency haematuria BURST Urology #BAUS25 in a packed room 🔥. Large variation in management of patients & length of stay. Lessons: #1. Mortality in these pts very high #2. Patients taken 2 theatre earlier <24 hrs may have shorter LOS

Exciting #WASHOUT preliminary findings emergency haematuria <a href="/BURSTurology/">BURST Urology</a> #BAUS25 in a packed room 🔥. Large variation in management of patients &amp; length of stay. Lessons: #1. Mortality in these pts very high #2. Patients taken 2 theatre earlier &lt;24 hrs may have shorter  LOS
𝙍𝙞𝙘𝙘𝙖𝙧𝙙𝙤 𝘽𝙚𝙧𝙩𝙤𝙡𝙤 MD PhD (@ricbertolo) 's Twitter Profile Photo

Università di Verona #urology team evaluation of 1-Night Catheterization Post-#HoLEP: 258 patients analyzed  📈 Higher re-catheterization in >1 day group (22% vs 1.5%) 🚫 Urinary tract infections major cause (53%) ✅ Early removal safe, reduces risks   🆓full-text rdcu.be/ethNO

<a href="/UniVerona/">Università di Verona</a> #urology team evaluation of 1-Night Catheterization Post-#HoLEP:

258 patients analyzed 
📈 Higher re-catheterization in &gt;1 day group (22% vs 1.5%)
🚫 Urinary tract infections major cause (53%)
✅ Early removal safe, reduces risks  

🆓full-text rdcu.be/ethNO
Orión Erenhú Rodríguez (@erenhu_gonzalez) 's Twitter Profile Photo

De mis cirugías favoritas!! #HOLEP estoy muy contento de poder haber reiniciado el programa de Enucleación que estaba detenido en mi Hospital, ya más de un año luchando por poder ofrecerlo y muchos pacientes felices. **Un esfuerzo conjunto con mis Anestesios y Enfermer@s**

Journal of Urology (@jurology) 's Twitter Profile Photo

Updates to Microhematuria: AUA/SUFU Guideline (2025) read the full article here! 👉 bit.ly/4kSNOOE #AUA #Urology #AUAmembers #TheVoiceofUrology

Updates to Microhematuria: AUA/SUFU Guideline (2025)

read the full article here! 👉 bit.ly/4kSNOOE
#AUA #Urology #AUAmembers #TheVoiceofUrology
Julio (@juliofdez79) 's Twitter Profile Photo

FÁRMACOS que CAMBIAN EL COLOR DE LA ORINA. La orina decolorada a menudo es causada por medicamentos, ciertos alimentos o colorantes alimentarios. En algunos casos, los cambios en el color de la orina pueden deberse a problemas de salud específicos.

FÁRMACOS que CAMBIAN EL COLOR DE LA ORINA. 
La orina decolorada a menudo es causada por medicamentos, ciertos alimentos o colorantes alimentarios. En algunos casos, los cambios en el color de la orina pueden deberse a problemas de salud específicos.
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

📢 Our article on ADT duration + salvage RT in prostate cancer (URONCOR 06-24 trial) is now online! 🧠 Open access for 50 days: 👉 authors.elsevier.com/c/1lUCL_4oIYIT… #ProstateCancer #RadiationOncology #ClinicalResearch #URONCOR0624

📢 Our article on ADT duration + salvage RT in prostate cancer (URONCOR 06-24 trial) is now online!
🧠 Open access for 50 days:
👉 authors.elsevier.com/c/1lUCL_4oIYIT…

#ProstateCancer #RadiationOncology #ClinicalResearch #URONCOR0624